BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Gu JN, Yao S, Cao YH, Deng SH, Mao FW, Jiang HY, He YT, Li XY, Ke SQ, Li HL, Li H, Liu XH, Liu HL, Wang JL, Wu K, Liu L, Cai KL. Novel parameter based on lipid indicators ratio improves prognostic value of plasma lipid levels in resectable colorectal cancer patients. World J Gastrointest Surg 2021; 13(7): 689-701 [PMID: 34354802 DOI: 10.4240/wjgs.v13.i7.689]
URL: https://www.wjgnet.com/1007-9327/full/v13/i7/689.htm
Number Citing Articles
1
Meijuan Tan, Shijie Yang, Xiequn Xu. High-density lipoprotein cholesterol and carcinogenesisTrends in Endocrinology & Metabolism 2023; 34(5): 303 doi: 10.1016/j.tem.2023.02.009
2
Răzvan Alexandru Marinescu, Daniela Marinescu, Lidia Boldeanu, Ana-Maria Ciurea, Marius Bică, Ștefan Pătrașcu, Victor Dan Eugen Strâmbu, Petru Adrian Radu, Petrica Popa, Mohamed-Zakaria Assani, Mihail Virgil Boldeanu, Valeriu Șurlin. Atherogenic Lipid Indices in Colorectal Cancer: Metabolic Associations and Survival OutcomesDiagnostics 2026; 16(5): 810 doi: 10.3390/diagnostics16050810
3
Jin-Hua Tao, Xiao-Tong Wang, Wei Yuan, Jia-Nan Chen, Zhi-Jie Wang, Yun-Bin Ma, Fu-Qiang Zhao, Liu-Yuan Zhang, Jie Ma, Qian Liu. Reduced serum high-density lipoprotein cholesterol levels and aberrantly expressed cholesterol metabolism genes in colorectal cancerWorld Journal of Clinical Cases 2022; 10(14): 4446-4459 doi: 10.12998/wjcc.v10.i14.4446
4
Hailun Xie, Lishuang Wei, Qiwen Wang, Shuangyi Tang, Jialiang Gan. Apolipoprotein A-I levels in the survival of patients with colorectal cancer: a retrospective studyFrontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1318416
5
Qiliang Peng, Changli Zhan, Yi Shen, Yao Xu, Bixin Ren, Zhengyang Feng, Yong Wang, Yaqun Zhu, Yuntian Shen. Blood lipid metabolic biomarkers are emerging as significant prognostic indicators for survival in cancer patientsBMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-13265-8